Skip to main content
SpringerLink
Log in
Book cover

Minimally Invasive Bariatric Surgery pp 1–6Cite as

1 The Global Burden of Obesity and Diabetes

  • Chapter
  • First Online:

  • 1692 Accesses

Abstract

The global pandemic of obesity and diabetes continues relentlessly in developed and developing nations. On a population basis, current preventative strategies for obesity and diabetes appear ineffective. The increase in obesity prevalence only partly explains the increase in diabetes prevalence. The increased prevalence and burden of diabetes in developed nations is generally occurring in an older population and is related to aging, reduced mortality associated with diabetes, an increase in the proportion in the population with high-diabetes-risk ethnicities, and increasing levels of obesity. In contrast in developing countries, the increased in diabetes prevalence and burden is in a younger working demographic and related to aging and rapid increase in those at risk related to obesity. Effective strategies for obesity-diabetes prevention and management at a population level are desperately needed globally.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Stevens GA, Singh GM, Lu Y, Danaei G, Lin JK, Finucane MM, Bahalim AN, McIntire RK, Gutierrez HR, Cowan M, Paciorek CJ, Farzadfar F, Riley L, Ezzati M. National, regional, and global trends in adult overweight and obesity prevalences. Popul Health Metr. 2012;10:22.

    Article  PubMed Central  PubMed  Google Scholar 

  2. Walls HL, Magliano DJ, Stevenson CE, Backholer K, Mannan HR, Shaw JE, Peeters A. Projected progression of the prevalence of obesity in Australia. Obesity (Silver Spring). 2012;20:872–8.

    Article  Google Scholar 

  3. Sturm R. Increases in morbid obesity in the USA: 2000-2005. Public Health. 2007;121:492–6.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  4. Walls HL, Wolfe R, Haby MM, Magliano DJ, de Courten M, Reid CM, McNeil JJ, Shaw J, Peeters A. Trends in BMI of urban Australian adults. Public Health Nutr. 1980–2000;2009:1–8.

    Google Scholar 

  5. IASO. USA prevalence of morbid obesity—adapted from the IASO website; 2013.

    Google Scholar 

  6. Ramachandran A, Snehalatha C, Shetty AS, Nanditha A. Trends in prevalence of diabetes in Asian countries. World J Diabetes. 2012;3:110–7.

    Article  PubMed Central  PubMed  Google Scholar 

  7. Li R, Lu W, Jiang QW, Li YY, Zhao GM, Shi L, Yang QD, Ruan Y, Jiang J, Zhang SN, Xu WH, Zhong WJ. Increasing prevalence of type 2 diabetes in Chinese adults in Shanghai. Diabetes Care. 2012;35:1028–30.

    Article  PubMed Central  PubMed  Google Scholar 

  8. Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, Shan Z, Liu J, Tian H, Ji Q, Zhu D, Ge J, Lin L, Chen L, Guo X, Zhao Z, Li Q, Zhou Z, Shan G, He J. Prevalence of diabetes among men and women in China. N Engl J Med. 2010;362:1090–101.

    Article  CAS  PubMed  Google Scholar 

  9. Hwang CK, Han PV, Zabetian A, Ali MK, Narayan KM. Rural diabetes prevalence quintuples over twenty-five years in low- and middle-income countries: a systematic review and meta-analysis. Diabetes Res Clin Pract. 2012;96:271–85.

    Article  PubMed  Google Scholar 

  10. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87:4–14.

    Article  CAS  PubMed  Google Scholar 

  11. Chang CH, Shau WY, Jiang YD, Li HY, Chang TJ, Sheu WH, Kwok CF, Ho LT, Chuang LM. Type 2 diabetes prevalence and incidence among adults in Taiwan during 1999-2004: a national health insurance data set study. Diabet Med. 2010;27:636–43.

    Article  CAS  PubMed  Google Scholar 

  12. Lipscombe LL, Hux JE. Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995-2005: a population-based study. Lancet. 2007;369:750–6.

    Article  PubMed  Google Scholar 

  13. Gregg EW, Cheng YJ, Saydah S, Cowie C, Garfield S, Geiss L, Barker L. Trends in death rates among U.S. adults with and without diabetes between 1997 and 2006: findings from the national health interview survey. Diabetes Care. 2012;35:1252–7.

    Article  PubMed Central  PubMed  Google Scholar 

  14. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317:703–13 [see comments] [published erratum appears in BMJ 1999 Jan 2;318(7175):29].

    Article  PubMed Central  Google Scholar 

  15. Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, Thomason MJ, Mackness MI, Charlton-Menys V, Fuller JH. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the collaborative atorvastatin diabetes study (cards): multicentre randomised placebo-controlled trial. Lancet. 2004;364:685–96.

    Article  CAS  PubMed  Google Scholar 

  16. Currie CJ, Peters JR, Tynan A, Evans M, Heine RJ, Bracco OL, Zagar T, Poole CD. Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study. Lancet. 2010;375:481–9.

    Article  CAS  PubMed  Google Scholar 

  17. McAllister EJ, Dhurandhar NV, Keith SW, Aronne LJ, Barger J, Baskin M, Benca RM, Biggio J, Boggiano MM, Eisenmann JC, Elobeid M, Fontaine KR, Gluckman P, Hanlon EC, Katzmarzyk P, Pietrobelli A, Redden DT, Ruden DM, Wang C, Waterland RA, Wright SM, Allison DB. Ten putative contributors to the obesity epidemic. Crit Rev Food Sci Nutr. 2009;49:868–913.

    Article  PubMed Central  PubMed  Google Scholar 

  18. Gluckman PD, Hanson MA. Developmental and epigenetic pathways to obesity: an evolutionary-developmental perspective. Int J Obes (Lond). 2008;32 Suppl 7:S62–71.

    Article  CAS  Google Scholar 

  19. Hillier TA, Pedula KL. Characteristics of an adult population with newly diagnosed type 2 diabetes: the relation of obesity and age of onset. Diabetes Care. 2001;24:1522–7.

    Article  CAS  PubMed  Google Scholar 

  20. Durand ZW. Age of onset of obesity, diabetes and hypertension in Yap State, Federated States of Micronesia. Pac Health Dialog. 2007;14:165–9.

    PubMed  Google Scholar 

  21. Carnethon MR, De Chavez PJ, Biggs ML, Lewis CE, Pankow JS, Bertoni AG, Golden SH, Liu K, Mukamal KJ, Campbell-Jenkins B, Dyer AR. Association of weight status with mortality in adults with incident diabetes. JAMA. 2012;308:581–90.

    PubMed Central  CAS  PubMed  Google Scholar 

  22. Tseng CH. Obesity paradox: differential effects on cancer and noncancer mortality in patients with type 2 diabetes mellitus. Atherosclerosis. 2013;226:186–92.

    Article  CAS  PubMed  Google Scholar 

  23. Logue J, Walker JJ, Leese G, Lindsay R, McKnight J, Morris A, Philip S, Wild S, Sattar N. The association between BMI measured within a year after diagnosis of type 2 diabetes and mortality. Diabetes Care. 2013;36(4):887–93.

    Article  PubMed Central  PubMed  Google Scholar 

  24. Kokkinos P, Myers J, Faselis C, Doumas M, Kheirbek R, Nylen E. BMI-mortality paradox and fitness in African American and Caucasian men with type 2 diabetes. Diabetes Care. 2012;35:1021–7.

    Article  PubMed Central  PubMed  Google Scholar 

  25. James WP, Caterson ID, Coutinho W, Finer N, Van Gaal LF, Maggioni AP, Torp-Pedersen C, Sharma AM, Shepherd GM, Rode RA, Renz CL. Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. N Engl J Med. 2010;363:905–17.

    Article  CAS  PubMed  Google Scholar 

  26. Adams TD, Gress RE, Smith SC, Halverson RC, Simper SC, Rosamond WD, Lamonte MJ, Stroup AM, Hunt SC. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357:753–61.

    Article  CAS  PubMed  Google Scholar 

  27. WHO. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157–63.

    Article  Google Scholar 

  28. WHO. Obesity: preventing and managing the global epidemic. Report of a who consultation. World Health Organ Tech Rep Ser. 2000;894:1–253.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Baker IDI Heart & Diabetes Institute, Clinical Obesity Research, Melbourne, VIC, Australia

    John B. Dixon M.B.S.B., Ph.D., F.R.A.C.G.P., F.R.C.P. (Edin)

Authors
  1. John B. Dixon M.B.S.B., Ph.D., F.R.A.C.G.P., F.R.C.P. (Edin)
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Cleveland Clinic Lerner College of Medicine, Bariatric and Metabolic Institute, Cleveland Clinic, Cleveland, Ohio, USA

    Stacy A. Brethauer

  2. Cleveland Clinic Lerner College of Medicine, Bariatric and Metabolic Institute, Cleveland Clinic, Cleveland, Ohio, USA

    Philip R. Schauer

  3. Department of Surgery, Health Sciences Center, University of Virginia Health System, Charlottesville, Virginia, USA

    Bruce D. Schirmer

Review Questions and Answers

Review Questions and Answers

Question 1

  • What is the expected change in the proportion of people with severe obesity (class II, III, and BMI > 50) as the prevalence of obesity rises in a community?

    1. (a)

      The rise in the prevalence of obesity leads to the same proportional rise in higher levels of obesity.

    2. (b)

      The proportional rise in severe forms of obesity is less than expected because limited numbers have the propensity to become severely and super obese.

    3. (c)

      The proportional (or percentage) rises far more rapid and becomes more so with higher BMI. The proportion of super obese (BMI >50) is rising rapidly.

    4. (d)

      There is insufficient data to know how many in our communities have the more severe forms of obesity.

  • The answer is C.

Question 2

  • The increasing prevalence of diabetes in developed countries such as the USA is related to:

    1. (a)

      Increased aging

    2. (b)

      Increased overweight and obesity rates

    3. (c)

      Increased survival of those with diabetes

    4. (d)

      Increased proportion within the population with a high ethnic risk

    5. (e)

      All of the above

  • The answer is E.

Question 3

  • Which of the following is true about diabetes prevalence in developing countries?

    1. (a)

      Diabetes rates are much lower than in developed countries.

    2. (b)

      Diabetes rates are only rising in urban regions.

    3. (c)

      The expected increase in diabetes will have its greatest impact in the working years of middle age rather than the elderly.

    4. (d)

      The expected increase in diabetes will have its greatest impact in elderly.

    5. (e)

      Diabetes is not a major health issue in developing countries as it is in the developed.

  • The answer is C.

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Dixon, J.B. (2015). 1 The Global Burden of Obesity and Diabetes. In: Brethauer, S., Schauer, P., Schirmer, B. (eds) Minimally Invasive Bariatric Surgery. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1637-5_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-1637-5_1

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-1636-8

  • Online ISBN: 978-1-4939-1637-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation